Does SPARSENTAN Cause Product distribution issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product distribution issue have been filed in association with SPARSENTAN (FILSPARI). This represents 0.2% of all adverse event reports for SPARSENTAN.
6
Reports of Product distribution issue with SPARSENTAN
0.2%
of all SPARSENTAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product distribution issue From SPARSENTAN?
Of the 6 reports.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPARSENTAN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SPARSENTAN Cause?
Dizziness (521)
Fatigue (448)
Hypotension (377)
Product use in unapproved indication (262)
Nausea (231)
Peripheral swelling (197)
Headache (186)
Pruritus (171)
Blood creatinine increased (145)
Glomerular filtration rate decreased (141)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which SPARSENTAN Alternatives Have Lower Product distribution issue Risk?
SPARSENTAN vs SPESOLIMAB-SBZO
SPARSENTAN vs SPIRAMYCIN
SPARSENTAN vs SPIRIVA
SPARSENTAN vs SPIRONOLACTONE
SPARSENTAN vs SPRYCEL